Apheris
CompanyAI is fundamentally dependent on data, but the vast majority of health data goes unused for understandable reasons — chiefly patient privacy, regulation, and IP protection. “This is the core underlying problem” of building AI solutions for life sciences and related areas like pharmaceutics, said German entrepreneur Robin Röhm.
Date
Jan 2, 2025
Category
devtools
Lead investor
OTB Ventures
Stage
Series A
Size
$20.8M
First Round Capital
CRV
Next47
a16z
Sequoia
GreatPoint Ventures
Lowercarbon Capital
Emergence Capital
Battery Ventures
Valor Equity Partners